12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Aug 27 at 07:05 AMACIU-0.38%VNRX-3.43%
Jeet Mukherjee Initiates Buy on Ascentage Pharma, Citing 2027 NRDL Lisaftoclax Catalyst, Late‑Stage Pipeline Readouts, and Cash Runway Through 2027Tip Ranks·Aug 21 at 09:05 AMAAPG-6.43%06855-3.17%
Transcript: Ascentage Pharma Group H1 2026 Earnings Conference Callbenzinga_article·Aug 21 at 01:07 AMAAPG-6.43%06855-3.17%
Ascentage Pharma appoints Faiçal Miyara chief business officer, names Jim Ziegler chief commercial officerPUBT·Aug 20 at 07:14 AMAAPG-6.43%06855-3.17%
Ascentage Pharma: Revenue up 29% YoY to $44.5M, with global trial progress and strengthened leadershipQuartr·Aug 20 at 12:32 AMAAPG-6.43%06855-3.17%
Ascentage Pharma posts interim results presentation on 1H 2026 business updatePUBT·Aug 19 at 08:16 PMAAPG-6.43%06855-3.17%
Ascentage Pharma: Revenue up 29%, but net loss widened on higher R&D and selling costs; cash reserves declinedQuartr·Aug 19 at 06:09 PMAAPG-6.43%06855-3.17%
Ascentage Pharma Lifts Revenue, Deepens Losses as U.S. Push and BTK Degrader Trials AdvanceTip Ranks·Aug 19 at 06:07 PMAAPG-6.43%06855-3.17%
Ascentage Pharma FY26 H1 loss widens to US$120.4 million; revenue rises 29% to US$44.5 millionPUBT·Aug 19 at 06:00 PMAAPG-6.43%06855-3.17%
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates | AAPG Stock NewsStockTitan·Aug 19 at 10:00 AMAAPG-6.43%06855-3.17%
Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results WebcastTip Ranks·Aug 13 at 08:57 AMAAPG-6.43%06855-3.17%
Ascentage Pharma corrects interim results release time to 7 a.m. EDT Aug. 19PUBT·Aug 13 at 08:30 AMAAPG-6.43%06855-3.17%
Ascentage Pharma management participates in Evercore ISI China Biotech Summit fireside chatPUBT·Aug 13 at 07:02 AMAAPG-6.43%EVR-1.27%
